The development of new pain relief methods to help patients with osteoarthritis is the focus of future research, and AMPK may be a new target for pain treatment, as its activation may play a role in pain management by inhibiting pain-related signaling and reducing nociceptive neuron sensitivity (Price et al., 2016). This evidence concerns the gene PRKAA1 and osteoarthritis.